Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for PF-03654746

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug PF-03654746?

PF-03654746 is an investigational drug.

There have been 6 clinical trials for PF-03654746. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.

The most common disease conditions in clinical trials are Narcolepsy, Rhinitis, Allergic, and Rhinitis. The leading clinical trial sponsors are Pfizer, Yale University, and [disabled in preview].

Recent Clinical Trials for PF-03654746
Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's SyndromePfizerPhase 2
A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's DiseasePfizerPhase 1
A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With NarcolepsyPfizerPhase 2

See all PF-03654746 clinical trials

Clinical Trial Summary for PF-03654746

Top disease conditions for PF-03654746
Top clinical trial sponsors for PF-03654746

See all PF-03654746 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.